Pre-consultation prevention summaries and reminders in general practice: cluster randomised controlled trial of effects on performance of preventive activities

Not Applicable

• Conditions: Conditions for which primary or secondary prevention is available and recommended in the RACGP Guidelines for Preventive Activities in General Practice 7th edition. This includes health problems in the following categories:CardiovascularInfectionInjuries and accidentsMetabolic and endocrineRenal and urogenitalReproductive health and childbirthCancer; Conditions for which primary or secondary prevention is available and recommended in the RACGP Guidelines for Preventive Activities in General Practice 7th edition. This includes health problems in the following categories: Cardiovascular; Infection; Injuries and accidents; Metabolic and endocrine; Renal and urogenital; Reproductive health and childbirth; Cancer; Other - Research that is not of generic health relevance and not applicable to specific health categories listed above

• Registration Number: ACTRN12611000421932
• Lead Sponsor: niversity of Adelaide

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-04-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 60000

Inclusion Criteria

Patient attends the practice during the trial

Exclusion Criteria

None.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Performance of indicated preventive activities, This will be measured by automated extraction and analysis of de-identified data from each patient's electronic medical record.[The data will accumulate throughout the one year trial period, and will be extracted at the end of the trial period.]

Secondary Outcome Measures

Name	Time	Method
umbers of consultations and fees billed during the trial. This will be measured by automated extraction and analysis of de-identified data from each patient's electronic medical and billing record.[The data will accumulate throughout the one year trial period, and will be extracted at the end of the trial period.]